Bicycle Therapeutics
Justin Bader is a highly experienced clinical pharmacology professional with a strong background in leading drug development efforts across various stages, particularly in oncology and infectious diseases. Currently serving as Director of Clinical Pharmacology at Bicycle Therapeutics since June 2022, Justin previously held positions at Spero Therapeutics and Karyopharm Therapeutics, where responsibilities included overseeing clinical pharmacology studies, managing cross-functional teams, and contributing to regulatory submissions. Justin's academic credentials include a Doctor of Pharmacy (PharmD) and an MBA from the University at Buffalo, complemented by roles in preclinical research and pharmaceutical practices spanning over a decade.
This person is not in any teams
This person is not in any offices
Bicycle Therapeutics
2 followers
Bicycle is pioneering a new class of therapies based on its bicyclic peptide platform.